MedPath

Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Daily Disposable Lens Wearers

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Narafilcon A contact lens
Device: Nelfilcon A contact lens
Registration Number
NCT01035905
Lead Sponsor
CIBA VISION
Brief Summary

The purpose of this study is to evaluate the extent to which symptoms improve in symptomatic contact lens wearers when fit with one of two different daily disposable contact lenses.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Currently wear daily disposable, spherical, soft lens wearers (except the two study products) for at least the past 6 months.
  • Habitually wear lenses for at least 8 hours per day and 4 days per week.
  • Report 2 or more qualifying symptoms with current contact lenses.
  • Able to achieve visual acuity of at least 20/40 in each eye with habitual and with study lenses at dispense.
  • Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion Criteria
  • Eye injury or surgery within twelve weeks immediately prior to enrollment.
  • Currently enrolled in any clinical trial.
  • Any use of ocular medications, exclusive of contact lens rewetting drops.
  • History of corneal or refractive surgery.
  • Cylinder correction greater than 1.00 D
  • Current monovision contact lens wearers.
  • Other protocol-defined inclusion/exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Narafilcon ANarafilcon A contact lensNarafilcon A contact lens
Nelfilcon ANelfilcon A contact lensNelfilcon A contact lens
Primary Outcome Measures
NameTimeMethod
Lens Awareness4 weeks of wear

Lens awareness, as interpreted by the subject and reported by the subject in a questionnaire as a single, retrospective evaluation of 4-week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being always. Four-week ratings were compared to baseline ratings, and a negative difference (4 week minus baseline) represented an improvement.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath